205 related articles for article (PubMed ID: 8380129)
21. Aflatoxin B1-induced TP53 mutational pattern in normal human cells using the FASAY (Functional Analysis of Separated Alleles in Yeast).
Paget V; Sichel F; Garon D; Lechevrel M
Mutat Res; 2008 Oct; 656(1-2):55-61. PubMed ID: 18725321
[TBL] [Abstract][Full Text] [Related]
22. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.
Bressac B; Kew M; Wands J; Ozturk M
Nature; 1991 Apr; 350(6317):429-31. PubMed ID: 1672732
[TBL] [Abstract][Full Text] [Related]
23. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
24. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
25. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
Qin L; Tang Z; Liu K
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
[TBL] [Abstract][Full Text] [Related]
26. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
[TBL] [Abstract][Full Text] [Related]
28. Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry.
Jackson PE; Qian GS; Friesen MD; Zhu YR; Lu P; Wang JB; Wu Y; Kensler TW; Vogelstein B; Groopman JD
Cancer Res; 2001 Jan; 61(1):33-5. PubMed ID: 11196182
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP.
Qian GS; Kuang SY; He X; Groopman JD; Jackson PE
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1126-9. PubMed ID: 12376521
[TBL] [Abstract][Full Text] [Related]
30. p53 point mutation enhanced by hepatic regeneration in aflatoxin B1-induced rat liver tumors and preneoplastic lesions.
Lee CC; Liu JY; Lin JK; Chu JS; Shew JY
Cancer Lett; 1998 Mar; 125(1-2):1-7. PubMed ID: 9566688
[TBL] [Abstract][Full Text] [Related]
31. Mutation of p53 gene in hepatocellular carcinoma in Taiwan.
Sheu JC; Huang GT; Lee PH; Chung JC; Chou HC; Lai MY; Wang JT; Lee HS; Shih LN; Yang PM
Cancer Res; 1992 Nov; 52(21):6098-100. PubMed ID: 1327523
[TBL] [Abstract][Full Text] [Related]
32. [Sequence alterations in p53 gene of hepatocellular carcinoma from high aflatoxin risk area in Guangxi].
Deng Z; Pan L; Ma Y
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):18-21. PubMed ID: 10743047
[TBL] [Abstract][Full Text] [Related]
33. Mutation at codon 249 of p53 gene in a human hepatoblastoma.
Kar S; Jaffe R; Carr BI
Hepatology; 1993 Sep; 18(3):566-9. PubMed ID: 8395458
[TBL] [Abstract][Full Text] [Related]
34. Mutations associated with in vivo aflatoxin B1-induced carcinogenesis need not be present in the in vitro transformations by this toxin.
Stanley LA; Mandel HG; Riley J; Sinha S; Higginson FM; Judah DJ; Neal GE
Cancer Lett; 1999 Apr; 137(2):173-81. PubMed ID: 10374839
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas.
Debuire B; Paterlini P; Pontisso P; Basso G; May E
Oncogene; 1993 Aug; 8(8):2303-6. PubMed ID: 8393166
[TBL] [Abstract][Full Text] [Related]
36. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
37. [Characteristics of high frequency 249 codon mutation of p53 gene in hepatocellular carcinoma in prevalent area of China].
Ming L; Yuan B; Thorgeirsson SS
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):122-4. PubMed ID: 11776852
[TBL] [Abstract][Full Text] [Related]
38. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
39. Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes.
Aguilar F; Hussain SP; Cerutti P
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8586-90. PubMed ID: 8397412
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma in patients from northern Sweden with acute intermittent porphyria: morphology and mutations.
Bjersing L; Andersson C; Lithner F
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):393-7. PubMed ID: 9162306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]